Covert Administration of Medicines Policy and Procedure

Similar documents
Wirral Community NHS Trust Consent Form 4

Patient agreement to investigation, treatment or procedure

Covert Administration of Medicines Policy and Procedure

Consent Policy and Procedure (Including Incapacity and Advance Directives)

MENTAL HEALTH ACT, MENTAL CAPACITY ACT JOINT PROCEDURE No 2 CONSENT TO TREATMENT AND COVERT ADMINISTRATION OF MEDICATION CONTENTS

PROCEDURE AND GUIDELINES FOR THE ADMINISTRATION OF MEDICATION IN FOOD OR DRINK TO PEOPLE UNABLE TO GIVE CONSENT TO OR WHO REFUSE TREATMENT MM10

SOUTH CENTRAL AMBULANCE SERVICE NHS FOUNDATION TRUST

NHS Continuing Healthcare Consent Form

Medication Administration Policy Community Health & Social Care

Patient identifier/label: Page 1 of 6. Patient s first names. Date of birth

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM DENOSUMAB. Patient s first names.

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM TRASTUZUMAB (HERCEPTIN) Patient s first names.

Advance Statements and Advance Decisions to Refuse Treatment Policy

Policies, Procedures, Guidelines and Protocols

NHS ~~- w~ (Authorised Signatory) Clinical Area. Covert Medication. NHS Tayside. Author: Nurse Prescribing Lead, Perth & Kinross CHP

THE NEWCASTLE UPON TYNE HOSPITALS NHS TRUST LIVING WILLS (ADVANCE REFUSAL OF TREATMENT) Effective: May 2002 Review May 2005

PATIENT AGREEMENT TO SYSTEMIC THERAPY: GENERIC CONSENT FORM. Patient s first names. Date of birth. Job title

Patient identifier/label: Page 1 of 5 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM IMATINIB. Patient s first names.

MENTAL CAPACITY ACT (MCA) AND DEPRIVATION OF LIBERTY SAFEGUARDS (DoLS) POLICY

Best practice guidance in covert administration of medication

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM VISMODEGIB. Patient s first names.

Advance Decision to Refuse Treatment (ADRT) Policy

Administration of Fluids by Sub-Cutaneous Infusion

South Tyneside NHS Foundation Trust. Clinical Policy. Chaperoning Policy. Review Date June 2011

UK LIVING WILL REGISTRY

Administering Medicine Policy

HEALTH CARE DIRECTIVE

PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM WEEKLY RITUXIMAB. Patient s first names. Date of birth

Policy for the use of Leave under Section 17 of the Mental Health Act 1983 (as amended) Version: 9

My Advance Decision to Refuse Treatment (ADRT)

Nursing Home Model Policy for West Virginia Physician Orders for Scope of Treatment (POST)

Policy on Gaining Consent

Informed consent practice standard

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM CYTARABINE CONTINUOUS INFUSION

YOUR RIGHT TO DECIDE YOUR RIGHT TO DECIDE YOUR RIGHT TO DECIDE

Advance Health Care Directive Form Instructions

Oral Ibrutinib (single agent)

Unit 301 Understand how to provide support when working in end of life care Supporting information

SELF - ADMINISTRATION OF MEDICINES AND ADMINISTRATION OF MEDICINES SUPPORTED BY FAMILY/INFORMAL CARERS OF PATIENTS IN COMMUNITY NURSING

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM DOCETAXEL + PREDNISOLONE. Patient s first names

CALIFORNIA ADVANCE HEALTH CARE DIRECTIVE

MAKING DECISIONS FOR PEOPLE WHO LACK CAPACITY

2

PATIENT INFORMATION AND CONSENT POLICY

Basic Guidelines for Using the Advance Health Care Directive Form

NHS HDL (2006) 34 abcdefghijklm

Mental Capacity Act Policy V3.00

ECT Reference: Version 4 Effective Date: 28/02/2017. Date

The Newcastle upon Tyne Hospitals NHS Foundation Trust

Medication Policy. Revised March 2013

Advance Directive Designation of Patient Advocate. 825 N. Center Ave Gaylord, MI MyOMH.org

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Access to Drugs Policy

Policy Review Sheet. Review Date: 14/10/16 Policy Last Amended: 19/10/17. Next planned review in 12 months, or sooner as required.

MND Factsheet 44 Advance Directives

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM PEGYLATED LIPOSOMAL DOXORUBICIN (CAELYX)

North Dakota: Advance Directive

ADVANCE HEALTH CARE DIRECTIVE Including Power of Attorney for Health Care (California Probate Code Sections effective JULY 1, 2000)

TANZANIA NURSING AND MIDWIFERY COUNCIL CODE OF ETHICS AND PROFESSIONAL CONDUCT FOR NURSES AND MIDWIVES IN TANZANIA

HSC Clinical Education Centre

I,,, Social Security number

GOOD PRACTICE GUIDE. The Adults with Incapacity Act in general hospitals and care homes

Social care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1

Advance Health Care Directives. Form Instructions

Managing medicines in care homes

Promoting the health and wellbeing of looked after children and young people:

Advance Directive Policy

CSAR. GUIDANCE DOCUMENT To assist practitioners in the completion of the Common Summary Assessment Report (CSAR).

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM FMD. Patient s first names.

Policy: L5. Patients Leave Policy (non Broadmoor) Version: L5/01. Date ratified: 8 th August 2012 Title of originator/author:

ADVANCE MEDICAL DIRECTIVES

Policy Document Control Page

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

Clinical Bleep Policy Version 4.0

Managing Medicines Policy

Welcome to the Intensive Community Service (ICS)

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

Advance Decisions to Refuse Treatment (ADRT) and Advance Statements Policy

General Chiropractic Council. Guidance consultation: Consent

UNDERSTANDING ADVANCE DIRECTIVES

SELF ADMINISTRATION OF MEDICATIONS PROGRAMME FOR REHABILITATION & RECOVERY SERVICES AND LOW/MEDIUM SECURE SERVICES

Individualised End of Life Care Plan for the Last Days or Hours of Life Patient name Hospital number Date of birth

ST GEMMA S HOSPICE POLICIES AND PROCEDURES

NURSE-LED DISCHARGE POLICY

MISSOURI Advance Directive Planning for Important Healthcare Decisions

Guide to the Continuing NHS Healthcare Assessment Process

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

NO TALLAHASSEE, June 30, Mental Health/Substance Abuse

Protected Mealtimes Policy

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM PAZOPANIB. Patient s first names.

STATUTORY FORM ADVANCE HEALTH CARE DIRECTIVE (California Probate Code Section 4701)

Code of professional conduct

Advance Directive Procedure

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM CHOP 21 + RITUXIMAB

Planning for Your Future Care

SET Mental Capacity Act and Deprivation of Liberty Safeguards Policy and Guidance

Performance and Quality Committee

Mental Health Act 2007: Workshop. Approved Clinicians and Responsible Clinicians. Participant Pack

Assistance and Administration of Medication for Domiciliary Care Staff

Caring for me Advanced Care Planning

Transcription:

1 Final Draft 1. Policy Covert Administration of Medicines Policy and Procedure 1.1 Why? The Nursing and Midwifery Council has recognised there will be instances where it is appropriate to administer medication covertly to clients or patients. As a general principle, by disguising medication in food or drink, the patient or client is being led to believe that they are not receiving medication, when in fact they are. The registered nurse, midwife or health visitor will need to be sure that what they are doing is in the best interest of the patient or client, and be accountable for this decision. The need for covert administration of medication is a practice which needs careful consideration, and should not become common practice. There are occasions when a person, for whatever disability, cannot give consent. This may be a short-term situation, or indeed may last many years. Conventional methods of administration of medicines include the form of medication and bodily routes of administration. In some cases the patient or client may have indicated consent or refusal at an earlier stage, while still competent. Where the patients or clients wishes are known, practitioners should respect them. Such a view may have been expressed orally or in writing as advance directives as living wills (see appendix 2 definition 1). 1.2 Who? All staff who administer medication 1.3 When? (Criteria) The policy applies to patients/clients who require some form of medication where: I. All attempts at conventional methods of administration have been unsuccessful II. Person to receive medication cannot, or will not give consent III. Covert administration of medication is believed to be in the best interests of the patient or client In the situation above, if all criteria apply, then the following procedure should be initiated.

2 2. Procedure 2.1 How? I. Complete consent form 4 when treatment can be given to a patient who is unable to consent refer to guidance (see appendix 1) II. To complete consent form 4, a minimum of 2 appropriate professionals must be signatories to the document. Wherever possible, both signatures will be of a different health professional group from the following: Nurses GPs Consultants Allied Health Professionals (including pharmacists) A relative, or recognised advocate should be invited to sign the consent form in addition to the professional signatories. If this invitation is refused, then a note should be recorded to reflect this. III. To ensure Best Practice and promote compliance, professionals should involve user, family, friends and / or advocate wherever possible and it is reasonably practicable. IV. The method of administration must be agreed with the pharmacist. V. The care team will clarify the position, if necessary with the Trust s legal representatives, where possible, before treatment is commenced. VI. Make a record in the Care Plan of the following: The decision to pursue this procedure Reason for procedure The initial review, (within one week of the decision to pursue the procedure, including who will co-ordinate this) Review dates (arranged at the initial review see appendix 2, definitions 2) Place a copy of the Consent Form 4 in the client s notes (see appendix 4) Method / dose of administration *If at any time, any of the criteria set out above in Consent Form 4 Sections B or C change, then a review must be set up immediately and the process re-initiated. Policy statement agreed by: Signed on behalf of Primary Care Trust by: e.g. Clinical Governance Group e.g. Clinical Lead Date: Review Date How policy will be communicated to staff

Appendix 1 Guidance on completion of Consent Form 4 for adults who are unable to consent to investigation or treatment in relation to Covert Administration of Medicines PAGE HEADING ITEM ACTION 1 2 PATIENT DETAILS SECTION A SECTION B SECTION C Responsible Health Professional Details of procedure or course of treatment proposed Assessment of patient s capacity Assessment of Patient s best interests 3 SECTION D Involvement of the patient s family and others close to the patient Name minimum of 2 persons Include the following: 1-Medication Prescribed Frequency Routes Dose Form 2-Covert Administration Method Crushed Method of disguise Diluted Other (specify) Tick appropriate box Needs to include consideration of the following: Treatment must be necessary to save life or Prevent deterioration or Ensure an improvement in the patient s physical health or Ensure an improvement in the patient s mental health Or Ensure the safety of others Seek signature if they wish 3

Appendix 2 References UKCC Position Statement on the Covert Administration of Medicines Disguising Medicine in Food and Drink September 2001 UKCC Register 33, Autumn 2000 page 7 Nursing & Midwifery Council, Guidelines for the Administration of Medicines April 2002 Primary Health Care Vol.II, No 8, October 2001 p24.25 Hiding medicines HSC 2001/2003, 22 November 2 01 Good Practice in Consent 4

Appendix 3 Definitions 1. Advance statement a statement concerning his/her treatment wishes by a person over 18 years of age and of full capacity made in advance of his/her incapacity or detention - a statement made by a person who understands the implications of their requests and sets out how they wish to be treated in the event that they become mentally incapacitated. 2. Reviews should be: - made by the multi-disciplinary care team - an initial review should take place 1 week after the decision - the decision will then be reviewed monthly However, there may be exceptional circumstance, which dictate otherwise. In such instances, decision and justification must be fully documented. 5

Consent form 4 Form for adults who are unable to consent to investigation or treatment consent form 4 Patient details (or pre-printed label) Patient s surname/family name. Patient's first name.. Date of birth.. Responsible health professional Job title.. NHS number (or other identifier)... Male Female Special requirements (eg other language/other communication method) To be retained in patient s notes 1

Consent form 4 Patient identifier/label All sections to be completed by health professional proposing the procedure A. Details of procedure or course of treatment proposed (NB see guidance to health professionals overleaf for details of situations where court approval must first be sought) B. Assessment of patient s capacity I confirm that the patient lacks capacity to give or withhold consent to this procedure or course of treatment because: the patient is unable to comprehend and retain information material to the decision; and/or the patient is unable to use and weigh this information in the decision-making process; or the patient is unconscious Further details (excluding where patient unconscious): for example how above judgements reached; which colleagues consulted; what attempts made to assist the patient make his or her own decision and why these were not successful. C. Assessment of patient s best interests To the best of my knowledge, the patient has not refused this procedure in a valid advance directive. Where possible and appropriate, I have consulted with colleagues and those close to the patient, and I believe the procedure to be in the patient s best interests because: (Where incapacity is likely to be temporary, for example if patient unconscious, or where patient has fluctuating capacity) The treatment cannot wait until the patient recovers capacity because: 2

Consent form 4 D Involvement of the patient s family and others close to the patient The final responsibility for determining whether a procedure is in an incapacitated patient s best interests lies with the health professional performing the procedure. However, it is good practice to consult with those close to the patient (e.g. spouse/partner, family and friends, carer, supporter or advocate) unless you have good reason to believe that the patient would not have wished particular individuals to be consulted, or unless the urgency of their situation prevents this. Best interests go far wider than best medical interests, and include factors such as the patient s wishes and beliefs when competent, their current wishes, their general well being and their spiritual and religious welfare. (to be signed by a person or persons close to the patient, if they wish) I/We have been involved in a discussion with the relevant health professionals over the treatment of.(patient s name). I/We understand that he/she is unable to give his/her own consent, based on the criteria set out in this form. I/We also understand that treatment can lawfully be provided if it is in his/her best interests to receive it. Any other comments (including any concerns about decision) Name.. Relationship to patient.. Address (if not the same as patient) Signature..Date If a person close to the patient was not available in person, has this matter been discussed in any other way (eg over the telephone?) Yes. No Details:. Signature of health professional proposing treatment The above procedure is, in my clinical judgement, in the best interests of the patient, who lacks capacity to consent for himself or herself. Where possible and appropriate I have discussed the patient s condition with those close to him or her, and taken their knowledge of the patient s views and beliefs into account in determining his or her best interests. I have/have not sought a second opinion. Signature.Date. Name (PRINT).. Job title.. Where second opinion sought, s/he should sign below to confirm agreement: Signature.Date Name (PRINT).. Job title.. 3

Consent form 4 Guidance to health professionals (to be read in conjunction with consent policy) This form should only be used where it would be usual to seek written consent but an adult patient (18 or over) lacks capacity to give or withhold consent to treatment. If an adult has capacity to accept or refuse treatment, you should use the standard consent form and respect any refusal. Where treatment is very urgent (for example if the patient is critically ill), it may not be feasible to fill in a form at the time, but you should document your clinical decisions appropriately afterwards. If treatment is being provided under the authority of Part IV of the Mental Health Act 1983, different legal provisions apply and you are required to fill in more specialised forms (although in some circumstances you may find it helpful to use this form as well). If the adult now lacks capacity, but has clearly refused particular treatment in advance of their loss of capacity (for example in an advance directive or living will ), then you must abide by that refusal if it was validly made and is applicable to the circumstances. For further information on the law on consent, see the Department of Health s Reference guide to consent for examination or treatment (www.doh.gov.uk/consent). When treatment can be given to a patient who is unable to consent For treatment to be given to a patient who is unable to consent, the following must apply: the patient must lack the capacity ( competence ) to give or withhold consent to this procedure AND the procedure must be in the patient s best interests. Capacity A patient will lack capacity to consent to a particular intervention if he or she is: unable to comprehend and retain information material to the decision, especially as to the consequences of having, or not having, the intervention in question; and/or unable to use and weigh this information in the decision-making process. Before making a judgement that a patient lacks capacity you must take all steps reasonable in the circumstances to assist the patient in taking their own decisions (this will clearly not apply if the patient is unconscious). This may involve explaining what is involved in very simple language, using pictures and communication and decision-aids as appropriate. People close to the patient (spouse/partner, family, friends and carers) may often be able to help, as may specialist colleagues such as speech and language therapists or learning disability teams, and independent advocates or supporters. Capacity is decision-specific : a patient may lack capacity to take a particular complex decision, but be quite able to take other more straight-forward decisions or parts of decisions. Best interests A patient s best interests are not limited to their best medical interests. Other factors which form part of the best interests decision include: the wishes and beliefs of the patient when competent their current wishes their general well-being their spiritual and religious welfare Two incapacitated patients, whose physical condition is identical, may therefore have different best interests. Unless the patient has clearly indicated that particular individuals should not be involved in their care, or unless the urgency of their situation prevents it, you should attempt to involve people close to the patient (spouse/partner, family and friends, carer, supporter or advocate) in the decision-making process. Those close to the patient cannot require you to provide particular treatment which you do not believe to be clinically appropriate. However they will know the patient much better than you do, and therefore are likely to be able to provide valuable information about the patient s wishes and values. Second opinions and court involvement Where treatment is complex and/or people close to the patient express doubts about the proposed treatment, a second opinion should be sought, unless the urgency of the patient s condition prevents this. Donation of regenerative tissue such as bone marrow, sterilisation for contraceptive purposes and withdrawal of artificial nutrition or hydration from a patient in PVS must never be undertaken without prior High Court approval. High Court approval can also be sought where there are doubts about the patient s capacity or best interests. 4

Covert Administration of Medication Policy Patient, client, refuses to take All conventional methods of admin have been unsuccessful Review concerns with MDT, explore alternatives Criteria for policy not met Criteria for Policy met (see section 1.3) Consult Trust s legal representative Involve carers and advocates where possible Agree method of administration with pharmacist Complete Consent form 4 Document decision to administer medication covertly in care plan. Review in one week and arrange dates for subsequent reviews